» Articles » PMID: 22684546

Aspirin for Elective Hip and Knee Arthroplasty: a Multimodal Thromboprophylaxis Protocol

Overview
Journal Int Orthop
Specialty Orthopedics
Date 2012 Jun 12
PMID 22684546
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Multimodal thromboprophylaxis includes preoperative thromboembolic risk stratification and autologous blood donation, surgery performed under regional anaesthesia, postoperative rapid mobilisation, use of pneumatic compression devices and chemoprophylaxis tailored to the patient's individual risk. We determined the 90-day rate of venous thromboembolism (VTE), other complications and mortality in patients who underwent primary elective hip and knee replacement surgery with multimodal thromboprophylaxis.

Methods: A total of 1,568 consecutive patients undergoing hip and knee replacement surgery received multimodal thromboprophylaxis: 1,115 received aspirin, 426 received warfarin and 27 patients received low molecular weight heparin and warfarin with or without a vena cava filter.

Results: The rate of VTE, pulmonary embolism, proximal deep vein thrombosis (DVT) and distal DVT was 1.2, 0.36, 0.45 and 0.36 %, respectively, in patients who received aspirin. The rates in those who received warfarin were 1.4, 0.9, 0.47 and 0.47 %, respectively. The overall 90-day mortality rate was 0.2 %.

Conclusions: Multimodal thromboprophylaxis in which aspirin is administered to low-risk patients is safe and effective following primary total joint replacement.

Citing Articles

Low-versus high-dose aspirin for venous thromboembolic prophylaxis after total joint arthroplasty: a systematic review and meta-analysis.

Mirghaderi P, Pahlevan-Fallahy M, Rahimzadeh P, Habibi M, Pourjoula F, Azarboo A J Orthop Surg Res. 2024; 19(1):848.

PMID: 39702480 PMC: 11657554. DOI: 10.1186/s13018-024-05356-w.


A Comparison between Enoxaparin and Aspirin in Preventing Deep Vein Thrombosis after Spine Surgery: A Randomized Clinical Trial.

Kavian A, Rezaee H, Darvari S, Mehrad-Majd H, Mashhadinejad H Arch Bone Jt Surg. 2024; 12(6):412-417.

PMID: 38919740 PMC: 11195039. DOI: 10.22038/ABJS.2024.74693.3458.


Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial.

PLoS One. 2024; 19(4):e0298152.

PMID: 38626226 PMC: 11020928. DOI: 10.1371/journal.pone.0298152.


Venous thromboembolism testing practices after orthopaedic trauma: prophylaxis regimen does not influence testing patterns.

Haac B, OHara N, Haut E, Manson T, Slobogean G, OToole R OTA Int. 2024; 7(2):e331.

PMID: 38623266 PMC: 11013691. DOI: 10.1097/OI9.0000000000000331.


Aspirin is a safe and effective thromboembolic prophylaxis after total knee arthroplasty: a systematic review and meta-analysis.

Za P, Papalia G, Franceschetti E, Rizzello G, Adravanti P, Papalia R Knee Surg Sports Traumatol Arthrosc. 2023; 31(10):4407-4421.

PMID: 37449989 DOI: 10.1007/s00167-023-07500-1.


References
1.
Gonzalez Della Valle A, Serota A, Go G, Sorriaux G, Sculco T, Sharrock N . Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty. Clin Orthop Relat Res. 2006; 444:146-53. DOI: 10.1097/01.blo.0000201157.29325.f0. View

2.
Falck-Ytter Y, Francis C, Johanson N, Curley C, Dahl O, Schulman S . Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl):e278S-e325S. PMC: 3278063. DOI: 10.1378/chest.11-2404. View

3.
Auer R, Schulman A, Tuorto S, Gonen M, Gonsalves J, Schwartz L . Use of helical CT is associated with an increased incidence of postoperative pulmonary emboli in cancer patients with no change in the number of fatal pulmonary emboli. J Am Coll Surg. 2009; 208(5):871-8. PMC: 6351075. DOI: 10.1016/j.jamcollsurg.2008.12.030. View

4.
Sharrock N, Gonzalez Della Valle A, Go G, Lyman S, Salvati E . Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 2008; 466(3):714-21. PMC: 2505231. DOI: 10.1007/s11999-007-0092-4. View

5.
Memtsoudis S, Gonzalez Della Valle A, Besculides M, Gaber L, Sculco T . In-hospital complications and mortality of unilateral, bilateral, and revision TKA: based on an estimate of 4,159,661 discharges. Clin Orthop Relat Res. 2008; 466(11):2617-27. PMC: 2565056. DOI: 10.1007/s11999-008-0402-5. View